Phoenix-based Barrow Neurological Institute CEO Michael Lawton told Bloomberg a replacement candidate is expected to have surgery in July. Earlier in 2024 Neuralink’s brain-implant device, designed to assist spinal cord injury patients, was successfully implanted in a man with paralysis.
The patient whose surgery was canceled has amyotrophic lateral sclerosis.
Neuralink didn’t respond to Bloomberg’s request for comment.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
